In a suburban Las Vegas plaza, the parking signs outside Eytan Klepach’s clinic read "American Male," a relic of a 2020 rebrand to American Medical Wellness that sought to broaden its appeal. The clinic claims to pioneer peptide supplements in the city, serving a mix of locals and medical tourists.

Testosterone prescriptions rose from 7.3mn in 2019 to over 11mn in 2024, a trend that has pushed many men toward direct‑to‑consumer telehealth and cash‑based clinics. Patients increasingly stack testosterone with peptides—injectable amino acids that target endogenous hormone production. While weight‑loss peptides such as GLP‑1s dominate headlines, hundreds of other compounds promise benefits from sexual health to muscle gain.

Regulators have largely barred most peptides in the U.S., U.K., and Europe, yet sellers like Klepach collaborate with pharmacies to prescribe analogues that skirt bans. The strategy has faced backlash after a 2023 longevity conference incident and a Nevada Pharmacy Board fine. The city hosted the inaugural Enhanced Games, where influencers openly used BPC‑157, TB‑500, and other peptides, sparking debate over efficacy and safety.

The market’s growth signals a shift in wellness priorities and offers investors a new revenue stream amid insurance gaps. Companies that can navigate regulatory hurdles while delivering credible science will capture the expanding segment of status‑driven Synergy seekers.